Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lil Valentin

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
BMC Medical Research Methodology|November 24, 2023
Multiclass risk models for ovarian malignancy: an illustration of prediction uncertainty due to the choice of algorithmAshleigh Ledger, Jolien Ceusters, Lil Valentin, et al.
Acta Obstetricia Et Gynecologica Scandinavica|July 22, 2024
Association between miRNAs in serum at 10-14 gestational weeks and spontaneous preterm deliveryTove Wikström, Sung Hye Kim, Anna-Lena Leverin, et al.
Artificial Intelligence in Medicine|December 3, 2011
Improved modeling of clinical data with kernel methodsAnneleen Daemen, Dirk Timmerman, Thierry Van den Bosch, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 22, 2020
Ultrasound, macroscopic and histological features of malignant ovarian tumorsFrancesca Moro, Valeria Verdecchia, Paola Romeo, et al.
Journal of the National Cancer Institute|November 15, 2007
Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125Ben Van Calster, Dirk Timmerman, Tom Bourne, et al.
BMJ Open|October 8, 2025
Head-to-head comparison of the RMI and ADNEX models to estimate the risk of ovarian malignancy: a systematic review and meta-analysis of external validation studiesLasai Barreñada, Ashleigh Ledger, Agnieszka Kotlarz, et al.
Clinical and Translational Medicine|September 14, 2022
Microbial and human transcriptome in vaginal fluid at midgestation: Association with spontaneous preterm deliveryTove Wikström, Sanna Abrahamsson, Johan Bengtsson-Palme, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2007
Inclusion of CA-125 does not improve mathematical models developed to distinguish between benign and malignant adnexal tumorsDirk Timmerman, Ben Van Calster, Davor Jurkovic, et al.
The Lancet. Oncology|March 15, 2016
Morcellation and risk of malignancy in presumed ovarian fibromas/fibrothecomasWouter Froyman, Chiara Landolfo, Frédéric Amant, et al.
Diagnostics (Basel, Switzerland)|June 3, 2017
Validation of the Performance of International Ovarian Tumor Analysis (IOTA) Methods in the Diagnosis of Early Stage Ovarian Cancer in a Non-Screening PopulationWouter Froyman, Laure Wynants, Chiara Landolfo, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
BMC Medical Research Methodology|November 24, 2023
Multiclass risk models for ovarian malignancy: an illustration of prediction uncertainty due to the choice of algorithmAshleigh Ledger, Jolien Ceusters, Lil Valentin, et al.
Acta Obstetricia Et Gynecologica Scandinavica|July 22, 2024
Association between miRNAs in serum at 10-14 gestational weeks and spontaneous preterm deliveryTove Wikström, Sung Hye Kim, Anna-Lena Leverin, et al.
Artificial Intelligence in Medicine|December 3, 2011
Improved modeling of clinical data with kernel methodsAnneleen Daemen, Dirk Timmerman, Thierry Van den Bosch, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 22, 2020
Ultrasound, macroscopic and histological features of malignant ovarian tumorsFrancesca Moro, Valeria Verdecchia, Paola Romeo, et al.
Journal of the National Cancer Institute|November 15, 2007
Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125Ben Van Calster, Dirk Timmerman, Tom Bourne, et al.
BMJ Open|October 8, 2025
Head-to-head comparison of the RMI and ADNEX models to estimate the risk of ovarian malignancy: a systematic review and meta-analysis of external validation studiesLasai Barreñada, Ashleigh Ledger, Agnieszka Kotlarz, et al.
Clinical and Translational Medicine|September 14, 2022
Microbial and human transcriptome in vaginal fluid at midgestation: Association with spontaneous preterm deliveryTove Wikström, Sanna Abrahamsson, Johan Bengtsson-Palme, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2007
Inclusion of CA-125 does not improve mathematical models developed to distinguish between benign and malignant adnexal tumorsDirk Timmerman, Ben Van Calster, Davor Jurkovic, et al.
The Lancet. Oncology|March 15, 2016
Morcellation and risk of malignancy in presumed ovarian fibromas/fibrothecomasWouter Froyman, Chiara Landolfo, Frédéric Amant, et al.
Diagnostics (Basel, Switzerland)|June 3, 2017
Validation of the Performance of International Ovarian Tumor Analysis (IOTA) Methods in the Diagnosis of Early Stage Ovarian Cancer in a Non-Screening PopulationWouter Froyman, Laure Wynants, Chiara Landolfo, et al.
Pageof 8